UT Southwestern Medical Center researchers are investigating existing, available drugs that could potentially help treat mild to moderate COVID-19 cases. This move by the number one hospital in Dallas and second in all of Texas reflects a growing recognition by researchers and clinicians that stopping COVID-19 from progressing to a more severe state is of paramount importance. Now the UT Southwestern is putting this urgency to action by opening up an outpatient COVID-19 trial site next to their COVID-19 drive-thru testing site right on the campus.
Focus on Containing the Disease Early
A growing recognition that the disease must be contained early now sets in the United States. TrialSite News covers research around the world; and in low-to middle-income countries (LMICs) with less capital and resources, this recognition was internalized earlier on. In the U.S, and other wealthy nations, the popular culture centers attention on vaccines and sophisticated biological-based treatments. As compelling as these approaches sound—and indeed are—the reality is that America is the epicenter of this pandemic. Clearly a focus on finding treatments to reduce the severity and help prevent...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).